PCI Versus Conservative Management Before TAVR in Patients With Significant Coronary Artery Disease: A Nationwide Instrumental Variable Analysis
Authors:
- Antros LoucaALAntros Louca
- Petur PeturssonPPPetur Petursson
- Joakim SundströmJSJoakim Sundström
- Andreas RückARAndreas Rück
- Stefan JamesSJStefan James
- Kristofer SkoglundKSKristofer Skoglund
- Mohammed MohammedMMMohammed Mohammed
- Anders JeppssonAJAnders Jeppsson
- Dan IoanesDIDan Ioanes
- Sebastian VölzSVSebastian Völz
- 1 April 2026
- journal article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (4) , e016337
Abstract
BACKGROUND: The optimal management of coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) remains unclear, and evidence supporting routine percutaneous coronary intervention (PCI) beforehand is limited. This study aimed to evaluate whether PCI before TAVR provides clinical benefit compared with conservative management in patients with significant coronary artery disease, using nationwide Swedish registry data. METHODS: This observational study included 2578 Swedish patients with significant coronary artery disease (≥50% angiographic stenosis or physiologically significant lesions) who underwent TAVR between 2008 and 2023. 1182 underwent PCI before TAVR, and 1396 were managed conservatively. The primary outcome was a composite of all-cause mortality, myocardial infarction, and urgent revascularization. Secondary outcomes included the individual components, cardiovascular mortality, any revascularization, stroke, and bleeding. The primary analysis used an instrumental variable approach based on each region’s quarterly PCI treatment preference to account for confounding. RESULTS: PCI was not associated with a significant difference in the primary composite outcome (instrumental variable–adjusted hazard ratio, 0.98 [95% CI, 0.85–1.14]; P =0.80) or in all-cause mortality, myocardial infarction, cardiovascular death, stroke, or urgent revascularization. PCI was, however, associated with a lower risk of any revascularization (adjusted hazard ratio, 0.46 [95% CI, 0.30–0.72]; adjusted P =0.002) and a higher risk of bleeding (instrumental variable–adjusted odds ratio, 1.59 [95% CI, 1.23–2.04]; adjusted P =0.002). CONCLUSIONS: In this nationwide cohort, PCI before TAVR did not improve survival or reduce urgent revascularization but did reduce nonurgent revascularization at the cost of increased bleeding. Decisions should be individualized, balancing ischemic and bleeding risks and considering anticipated coronary access after TAVR.Keywords
This publication has 39 references indexed in Scilit:
- Coronary angiography following transcatheter aortic valve replacement: Insights from the SWEDEHEART registryCatheterization and Cardiovascular Interventions, 2024
- Large Sample Properties of Entropy Balancing Estimators of Average Causal EffectsEconometrics and Statistics, 2023
- Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysisNetherlands Heart Journal, 2023
- The Mortality Burden of Untreated Aortic StenosisJACC, 2023
- Sensitivity Analyses for Unmeasured ConfoundersCurrent Epidemiology Reports, 2022
- Coronary Cannulation After Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2020
- Procedural Characteristics and Late Outcomes of Percutaneous Coronary Intervention in the Workup Pre-TAVRJACC: Cardiovascular Interventions, 2020
- The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical researchEuropean Journal of Epidemiology, 2019
- Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE‐2 registryClinical Cardiology, 2017
- Management of concomitant coronary artery disease in patients undergoing transcatheter aortic valve implantation: The United Kingdom TAVI RegistryInternational Journal of Cardiology, 2015